Tom Chivers on Muck Rack

Tom Chivers

Verified
London
As seen in: Semafor, Apple Podcasts, CNN, CNN en Español, MSN UK, Yahoo Entertainment, Yahoo Life, The Guardian, The Independent (UK), The Telegraph, Yahoo News and
"Far too nice to be a journalist": Terry Pratchett. Lead writer, Flagship. Semafor. chiversthomas(a)gmail. Third book, Everything is Predictable, out now!
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Tom

Contact Tom, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Argentina begins construction of new nuclear reactor Original

|
By Tom Chivers Verified
| Semafor Verified
Argentina announced the construction of a new nuclear reactor and the UK extended the life of one of its existing ones, part of a worldwide revival of atomic energy. The Buenos Aires project is backed by $1.2 billion in US money; Britain’s Sizewell B will now run until 2055 rather than 2035.
Open in Who Shared View Duplicates (2) Issue with article?

Mexico makes first LNG shipment to Asia Original

|
By Tom Chivers Verified
| Semafor Verified
The first shipment of Mexican natural gas to Asia is en route, evidence of the reshaping of global energy markets. Mexico’s new LNG export terminal is one of several developments on the Pacific coast of the Americas, with confidence in traditional export avenues waning. Five years ago, the two main arteries for international oil and gas trade were Russian LNG pipelines to Europe, and the Middle East to Asia via the Strait of Hormuz.
Open in Who Shared View Duplicates (2) Issue with article?

GLP-1 use reaches new high in US Original

|
By Tom Chivers Verified
| Semafor Verified
The percentage of US citizens currently taking GLP-1 drugs such as Wegovy for weight loss has almost quadrupled to 11% from 3% in 2024. A further 4% of Americans say they’ve used the drugs in the past, Gallup polling found. Meanwhile, US obesity rates, which peaked in 2022 at 39.9%, fell further to 36.4%, suggesting, although not proving, a causal link.
Open in Who Shared View Duplicates (2) Issue with article?
See all 3,553 licensed articles (4,642 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified